News

July 13, 2011 โ€“ Many children and teens suffering from tachycardia, or rapid heart rate, have relied on medication to regulate their heart rhythms and control symptoms such as fatigue, dizziness and fainting spells. However, doctors at the Akron Children's Hospital Arrhythmia Center have made great strides in curing tachycardia with minimally invasive procedures.

Home July 13, 2011
Home
News

July 13, 2011 โ€“ The TandemHeart circulatory support system has been granted expanded reimbursement coverage by NHIC Corp., the medicare administrative contractor (MAC) serving over 1.3 million beneficiaries and over 53,000 healthcare providers in the Northeast region of the United States.

Home July 13, 2011
Home
News

July 13, 2011 โ€“ Based on its recent analysis of the medical imaging market, Siemens Healthcare was given the 2011 North American Frost & Sullivan Award for New Product Innovation. Siemens' Biograph mMR is the first scanner capable of simultaneously acquiring whole-body positron emission tomography (PET) and magnetic resonance imaging (MRI) data.

Home July 13, 2011
Home
Technology

July 12, 2011 โ€“ To streamline diagnosis and enable greater overall exam efficiency, Toshiba America Medical Systems Inc. has announced U.S. Food and Drug Administration (FDA) approval of VirtualExplorer Version 3.1, a software upgrade package for Toshiba Magnetic Resonance (MR) VirtualExplorer workstations. The software provides enhanced post-processing functionality, and the new cardiac package includes MR flow analysis, which allows clinicians to measure flow and velocity when imaging the heart.

Home July 12, 2011
Home
News

July 12, 2011โ€“ A heart valve developer that was spun-off out of Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets has received $3.5 million in equity investment from CryoLife Inc.

Home July 12, 2011
Home
News

July 12, 2011 โ€“ The Society of Cardiovascular Computed Tomography (SCCT) has published the SCCT Guidelines on Radiation Dose and Dose-Optimization Strategies in Cardiovascular CT document, which will be printed in the July/August special Radiation Focus issue of the Journal of Cardiovascular Computed Tomography. This guideline document reviews available data and provides recommendations regarding interpretation of radiation dose indices and predictors of risk, appropriate use of scanner acquisition modes and settings, development of algorithms for dose optimization and establishment of procedures for dose monitoring.

Home July 12, 2011
Home
Technology

July 12, 2011 โ€“ The Interlock-35 Fibered IDC Occlusion System has been launched in the United States and Europe. Earlier this year, the system, manufactured by Boston Scientific, received clearance from the U.S. Food and Drug Administration (FDA) and CE mark approval for obstructing or reducing blood flow in the peripheral vasculature during embolization procedures.

Home July 12, 2011
Home
News

July 7, 2011 โ€“ The National Aeronautics and Space Administration (NASA)โ€™s Ames Research Center and The Midura Laboratory selected ImageIQ to assist in their study of space flight-induced vascular alterations in the lower leg. ImageIQ will provide customized image acquisition and analysis for a vascular research study aboard NASA's final mission of the shuttle Atlantis. scheduled for July 8. The company provides imaging analytics software engineering and visualization services for research, medical device and pharmaceutical organizations.

Home July 07, 2011
Home
News

July 5, 2011 โ€” Janssen Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban tablets), a novel, once-daily, oral anticoagulant for the prevention (prophylaxis) of deep vein thrombosis (DVT) which may lead to a pulmonary embolism (PE) in people undergoing knee or hip replacement surgery.

Home July 05, 2011
Home
News

July 5, 2011 โ€” ECRI Institute, an independent nonprofit that researches the best approaches to improving patient care, and the Health Care Improvement Foundation, an independent nonprofit corporation with a multi-dimensional focus on healthcare safety, announced the launch of a new Partnership for Patient Care regional collaborative focused on improving computed tomography (CT) radiation safety. Jointly funded by Philadelphia-area hospitals and Independence Blue Cross, this collaborative will engage hospitals and imaging centers in Philadelphia and surrounding counties in a 12-month project aimed at strengthening patient safety specific to CT imaging.

Home July 05, 2011
Home
News

July 5, 2011 โ€“ A statement was issued by Peter W. Carmel, M.D., the president of the American Medical Association (AMA), regarding cuts to Medicare payments for diagnostic imaging.

Home July 05, 2011
Home
News

June 30, 2011 โ€” Micell Technologies Inc. announced that it has completed its review of the scheduled four-month follow-up on the first 10 patients from the DESSOLVE I first-in-human trial of the MiStent drug-eluting coronary stent system ("MiStent DES"), an ultra-thin drug-eluting stent (DES) distinguished by a rapid-absorbing drug/polymer coating formulation. Based on results observed in the DESSOLVE I trial, Micell has reduced the sample size in its DESSOLVE II CE Mark study from 270 to 171 planned subjects.

Home June 30, 2011
Home
News

June 30, 2011 โ€” The MemorialCare Heart and Vascular Institute (MHVI) at Long Beach Memorial has acquired the C7-XR OCT intravascular imaging system from St. Jude Medical. It is an imaging technology platform that aids physicians in the diagnosis and treatment of cardiovascular disease. Using optical coherence tomography (OCT), the system utilizes near-infrared light to create images that go beyond older coronary imaging technologies - such as fluoroscopy and intravascular ultrasound (IVUS) - offering cardiologists an assessment method with enhanced clarity for their patients with coronary artery disease.

Home June 30, 2011
Home
News

June 30, 2011 โ€” Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc. announced today that two additional analyses from phase 3 studies of mipomersen were presented at the 79th European Atherosclerosis Society (EAS) congress.

Home June 30, 2011
Home
News

June 30, 2011 โ€” During the first quarter of 2011, Biosound Esaote completed a name transition to become Esaote North America. The purpose of this transition was to emphasize the relationship with its parent company, the Esaote Group.

Home June 30, 2011
Home
Subscribe Now